| Product Name | NebuSelect™ Recombinant Cynomolgus ADAM9, His-tag |
|---|---|
| Catalog Number | NBL-241317 |
| Alias/Synonyms | ADAM9 |
| Appearance | see COA |
| Molecule Weight | Ala29-Gly698 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | A0A2K5X4X8 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241317-100ug | 100ug | Inquire | Inquire | |
| NBL-241317-1mg | 1mg | Inquire | Inquire | |
| NBL-241317-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus ADAM9, His-tag
Catalog#:
NBL-241317
Description:
NebuSelect™ Recombinant Cynomolgus ADAM9, His-tag(Cat#NBL-241317) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala29-Gly698.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 74.90 kDa. Due to furin cleavage site, the mature form migrates to 65-115 kDa based on Bis-Tris PAGE result.
Target Name:
ADAM9
Target Information:
A disintegrin and metalloproteinase 9 (ADAM9) is a member of the transmembrane ADAM family. It is expressed in different types of solid cancer and promotes tumor invasiveness. ADAM9 may be a prognostic marker for vestibular schwannomas (VS), and ADAM9 inhibition might have the potential as a systemic approach for the treatment of VS.
Amino Acid Sequence:
Ala29-Gly698
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.